These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1143 related articles for article (PubMed ID: 7425670)

  • 1. Studies of cellular mediated immunity in malignant melanoma patients by Leukocyte Adherence Inhibition Test.
    Müller S; Ernst TM
    Arch Dermatol Res; 1980; 268(2):167-81. PubMed ID: 7425670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocyte adherence inhibition and specific immunoreactivity in malignant melanoma.
    Halliday WJ; Maluish AE; Little JH; Davis NC
    Int J Cancer; 1975 Oct; 16(4):645-58. PubMed ID: 51836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cell-mediated immunity in patients with malignant melanoma.
    Fixa B; Komárková O; Kraus Z; Simková H
    Neoplasma; 1978; 25(3):353-7. PubMed ID: 683378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumour immunity in malignant melanoma assay by tube leucocyte adherence inhibition.
    Marti JH; Thomson DM
    Br J Cancer; 1976 Aug; 34(2):116-33. PubMed ID: 962991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunologic response in patients with melanoma of the skin].
    Mutsenietse AIa; Volrat AA; Popena BA; Bumbieris IaV; Shapovalova EA
    Vopr Onkol; 1983; 29(4):34-8. PubMed ID: 6858048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunity to melanoma associated antigens detected by both leukocyte adherence inhibition and antibody dependent cellular cytotoxicity assays.
    Plain MJ; Whitehead RH; Jose DG
    Pathology; 1983 Apr; 15(2):177-82. PubMed ID: 6888965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity to tumor-associated antigens in vasectomized men.
    Anderson DJ; Alexander NJ; Fulgham DL; Vandenbark AA; Burger DR
    J Natl Cancer Inst; 1982 Sep; 69(3):551-5. PubMed ID: 6180209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of leukocyte adherence by a 3 M potassium chloride extracts of human malignant melanoma.
    Ichiki AT; Quirin YP; Krauss S; Sonoda T
    Cancer Lett; 1981 Apr; 12(3):259-69. PubMed ID: 7020923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmembrane signal defect and absence of cancer extract induced leukocyte adherence inhibition (LAI) for leukocytes from patients with advanced cancer.
    Shenouda G; Thomson DM
    Cancer Immunol Immunother; 1984; 18(1):59-68. PubMed ID: 6333270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leucocyte adherence inhibition test for the detection of cell-mediated immunity to malignant melanoma.
    Winter M; Nelson DS; Milton GW
    Aust N Z J Med; 1980 Aug; 10(4):405-9. PubMed ID: 7000060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunotherapy].
    Lejeune FJ; Bernheim JL; Vanwijck R
    Acta Chir Belg; 1974 Mar; 73(2):265-93. PubMed ID: 4450923
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of leukocyte adherence by potassium chloride extract of allogeneic squamous cell carcinoma of the human uterine cervix.
    Dini MM; Lenzi L; Faiferman I
    Am J Reprod Immunol (1980); 1983 Jun; 3(4):188-90. PubMed ID: 6881415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunologic and histopathologic changes of BCG-mediated tumor regression in patients with malignant melanoma.
    Lieberman R; Wybran J; Epstein W
    Cancer; 1975 Mar; 35(3):756-77. PubMed ID: 234295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
    Halliday WJ; Koppi TA; Khan JM; Davis NC
    J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-mediated immunity to melanoma-associated antigens in patients with ocular malignant melanoma.
    Char DH; Jerome L; McCoy JL; Herberman RB
    Am J Ophthalmol; 1975 May; 79(5):812-6. PubMed ID: 1146943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leucocyte adherence inhibition assay for cell-mediated immunity and immunodiagnosis of pancreatic cancer.
    Onji M
    Gastroenterol Jpn; 1984 Aug; 19(4):328-35. PubMed ID: 6333369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human thoracic duct cannulation: manipulation of tumor-specific blocking factors in a patient with malignant melanoma.
    Isbister WH; Noonan FP; Halliday WJ; Clunie GJ
    Cancer; 1975 May; 35(5):1465-71. PubMed ID: 1122496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cellular immunity in melanomalignome (author's transl)].
    Fritz J; Grond K; Tilz GP
    Arch Dermatol Res (1975); 1976 Apr; 255(2):203-9. PubMed ID: 1275554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview: antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition.
    Flores M; Marti JH; Grosser N; MacFarlane JK; Thomson DM
    Cancer; 1977 Feb; 39(2):494-505. PubMed ID: 319891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma.
    McCoy JL; Jerome LF; Dean JH; Perlin E; Oldham RK; Char DH; Cohen MH; Felix EL; Herberman RB
    J Natl Cancer Inst; 1975 Jul; 55(1):19-23. PubMed ID: 1057654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.